Page 2 - Mini Oral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immutep Announces Publication of Abstracts at ESMO Congress 2023

Media ReleaseNew updated data from TACTI-002, including more mature Overall Survival data, will be presented during the Mini Oral session on Satur.

New south walesUnited statesEnric carcerenyChris bastaFlorian voglKatarzyna kozakChristian muellerFrederic triebelMarc voigtKrankenhaus nordwestCatalan institute of oncologyMerck co incStrategic developmentImmutep limitedCurie national research institute of oncologyCorporate communications

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSean leousGuo liang yuJin ji yangPeter vozzoEuropean society of medical oncology congressApollomics incGiulia cerretti veneto institute of oncologySouthern medical universitySecurities exchangeExchange commissionVeneto institute of oncologyGuangdong academy of medical sciencesGuangdong lung cancer institutePearl biotechnology coEuropean society

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJin ji yangGuo liang yuSean leousPeter vozzoExchange commissionGuangdong academy of medical sciencesSecurities exchangeVeneto institute of oncologyEuropean society of medical oncology congressSouthern medical universityApollomics incGuangdong lung cancer instituteGiulia cerretti veneto institute of oncologyPearl biotechnology coAnnounces presentations

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

FOSTER CITY, Calif., Oct. 16, 2023 Apollomics Inc. , a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and.

United statesJin ji yangGuo liang yuSean leousPeter vozzoVeneto institute of oncologyGuangdong lung cancer instituteGuangdong academy of medical sciencesPearl biotechnology coSecurities exchangeExchange commissionSouthern medical universityGiulia cerretti veneto institute of oncologyEuropean society of medical oncology congressApollomics incEuropean society

Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023

Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesEnfortumab vedotinM ruiz vicoNaoki okamuraMoitreyee chatterjee kishoreAhsan arozullahOncology developmentAstellas pharma incEuropean society for medical oncologyMedivation incHead of oncology developmentMerck sharp dohme corpMerck co incPrnewswire astellas pharma incEuropean societyMedical oncology